TAG is hosting a series of webinars on COVID-19 biomedical prevention research in collaboration with the CoVPN. Information and videos from the first two events are provided below.
Update on CoVPN’s Current Research, Future Plans, and Community Engagement
On Tuesday November 24th, Treatment Action Group (TAG) hosted a webinar for community advocates to provide an update on the COVID-19 Prevention Network’s current research, future plans and community engagement. The webinar discussed the latest in biomedical COVID-19 prevention research, including how the landscape may evolve after the first reports of vaccine efficacy.
Lawrence Corey, M.D,
Past President and Director
Professor, Vaccine and Infectious Disease Division
Principal Investigator, HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center
Professor, Medicine and Laboratory Medicine, University of Washington
Stephaun Elite Wallace, Ph.D., M.S.
Staff Scientist, Vaccine and Infectious Disease Division, Fred Hutch
Director of External Relations, HIV Vaccine Trials Network, Fred Hutch
Clinical Assistant Professor, Dept. of Global Health, University of Washington
Executive Director, Treatment Action Group
Webinar: Diverse Communities in COVID-19 Biomedical Prevention Trials
On Thursday December 10th, Treatment Action Group (TAG) hosted a webinar for community advocates on involving diverse communities in COVID-19 biomedical prevention trials. The webinar aimed to:
- Review enrollment in key COVID-19 vaccine research and other biomedical prevention studies
- Discuss the importance of recruiting diverse populations in COVID-19 biomedical prevention trials and broad community engagement
Michele Andrasik, Ph.D.
Director, Social & Behavioral Sciences and Community Engagement, HIV Vaccine Trials Network
Senior Staff Scientist, Vaccine and Infectious Disease Division, Fred Hutch
Clinical Assistant Professor Global Health, University of Washington
Adrianna Boulin, MPH
Community Engagement Manager, The Fenway Institute